Fasting Serum Insulin (Fasting Insulin)
Fasting serum insulin measures baseline pancreatic beta-cell peptide hormone secretion. Hyperinsulinemia precedes overt elevations in blood glucose by 10 to 15 years in the pathogenesis of metabolic disease.
Standard vs. Optimal Reference RangesμIU/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
2.6 - 24.9 μIU/mL
General reference distribution across unselected commercial populations.
2.0 - 5.0 μIU/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Insulin binds the insulin receptor tyrosine kinase, activating IRS-1 and PI3K-Akt pathways to translocate GLUT4 vesicles to skeletal muscle and adipose cell membranes while downregulating FOXO1-driven hepatic gluconeogenesis.
Differential Diagnosis
Elevated Levels (Fasting Insulin High)
- •Peripheral insulin resistance (Metabolic Syndrome)
- •Type 2 Diabetes (hyperinsulinemic phase)
- •Insulinoma
- •Polycystic Ovary Syndrome (PCOS)
Low Levels (Fasting Insulin Low)
- •Type 1 Diabetes Mellitus (absolute beta-cell failure)
- •Late-stage Type 2 Diabetes (beta-cell exhaustion)
- •Pancreatitis / Pancreatectomy
- •Extreme insulin sensitivity in elite athletes
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Strict 10 to 12 hour overnight water-only fasting is mandatory for baseline metabolic quantification. Acute psychological stress, acute infectious illness, and sleep deprivation (<6 hours) transiently elevate cortisol and catecholamines, falsely elevating glycemic markers. For glucose and insulin testing, draw blood into sodium fluoride/potassium oxalate tubes or separate serum promptly within 30 minutes to prevent ongoing in vitro red blood cell glycolysis.
Reflexive Testing Protocol:
- Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and HOMA-Beta calculations
- Continuous Glucose Monitoring (CGM) 14-day wear to evaluate glycemic variability and postprandial excursions
- Fasting C-Peptide and high-sensitivity Troponin/hs-CRP to differentiate insulin resistance from beta-cell exhaustion
- Oral Glucose Tolerance Test (OGTT) with simultaneous 0, 30, 60, and 120-minute insulin assays
- Abdominal ultrasound or FibroScan to evaluate hepatic steatosis and non-alcoholic fatty liver disease (MASLD)
Clinical Citations & Primary Literature (1)
- [1]Hyperinsulinemia as an Independent Risk Factor for Vascular and Metabolic Disease - Cell Metabolism (2021). PMID: 33497607
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Fasting Serum Insulin (Fasting Insulin) into overall healthspan optimization.